FeesSafety
Pluang+

Kimberly-Clark completes $7B note exchange offer for Kenvue notes, issuing new notes and cash to holders.

Company Fundamentals
03 Nov 2026, 16:10 WIB
PRNewsWire
View Source
Neutral
Kimberly-Clark completes $7B note exchange offer for Kenvue notes, issuing new notes and cash to holders.

Kimberly-Clark finalized its $7 billion exchange offer, swapping outstanding Kenvue LLC notes for new Kimberly-Clark notes plus cash. The exchange includes amendments to the Kenvue notes' indenture and offers an early participation premium. Settlement is expected on November 4, 2026, with Kimberly-Clark notes matching the original notes' terms but ranking as unsecured senior obligations. This move restructures debt and consolidates obligations under Kimberly-Clark, impacting noteholders and the company's debt profile.

Kimberly-Clark's stock price is currently USD 107.48 on Pluang as of Nov 03, 2026 21:22 WIB. The share price has declined by 0.71% in the last day, reflecting some market caution. The company holds a market capitalization of $36.00 billion, with a dividend yield of 4.73%, while Pluang order activity shows a full sell interest at this time.

More News (KMB)

Kenvue exits S&P 500 as Kimberly-Clark acquires it; Okta replaces Kenvue in the index.

Kenvue exits S&P 500 as Kimberly-Clark acquires it; Okta replaces Kenvue in the index.

Kenvue is leaving the S&P 500 due to its acquisition by Kimberly-Clark, which is expected to close soon. Kenvue shareholders will receive $3.50 in cash plus Kimberly-Clark shares for each Kenvue share at closing. Okta will replace Kenvue in the S&P 5...

Market News
Neutral
1 day ago
Kimberly-Clark completes acquisition of Kenvue, creating a global consumer health leader with $2.1B synergies.

Kimberly-Clark completes acquisition of Kenvue, creating a global consumer health leader with $2.1B synergies.

Kimberly-Clark has finalized its acquisition of Kenvue, forming a leading global consumer health and wellness company with 10 billion-dollar brands including Huggies and Tylenol. The combined entity aims to leverage Kimberly-Clark's growth engine and...

Company Fundamentals
Bullish
1 day ago
Investors advised to shift from AI to consumer staples, with key stocks surging over 11% in October.

Investors advised to shift from AI to consumer staples, with key stocks surging over 11% in October.

Jim Cramer recommends investors diversify away from struggling AI stocks and consider consumer staples, which rose 11.4% in October. He highlights Kimberly-Clark, Procter & Gamble, Constellation Brands, and Coca-Cola as attractive picks due to their ...

Market News
Bullish
3 days ago
Kimberly-Clark raises $4.9B via senior notes to fund Kenvue acquisition and support growth.

Kimberly-Clark raises $4.9B via senior notes to fund Kenvue acquisition and support growth.

Kimberly-Clark has completed a $4.9 billion private offering of senior unsecured notes in five tranches with maturities from 2028 to 2036. The proceeds will help fund its planned acquisition of Kenvue Inc. and cover related fees, with any remaining f...

Company Fundamentals
Neutral
4 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App